Earnings Feed
Start Free
Home/Filings/4/0001440766-11-000002
4//SEC Filing

Dingivan Christine A 4

Accession 0001440766-11-000002

CIK 0001003124other
View on SEC.govCompany Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:14 PM ET

Size

17.1 KB

Accession

0001440766-11-000002

Insider Transaction Report

Form 4
Period: 2011-02-23
PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI
Dingivan Christine A
EVP/Chief Medical Officer
Transactions
  • Award

    Stock Options (to buy)

    2011-02-23+45,000→ 45,000 total
    Exercise: $27.27From: 2012-02-23Exp: 2021-02-23→ Common Stock (45,000 underlying)
  • Award

    Restricted Stock Units

    2011-02-23+15,000→ 15,000 total
    → Common Stock (15,000 underlying)
Holdings

  • Stock Option (to buy)

    Exercise: $26.64From: 2011-06-17Exp: 2020-06-17→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (to buy)

    Exercise: $37.69From: 2009-10-03Exp: 2018-10-03→ Common Stock (7,763 underlying)
    7,763

  • Stock Option (to buy)

    Exercise: $20.45From: 2011-02-25Exp: 2020-02-25→ Common Stock (41,403 underlying)
    41,403

  • Stock Options (to buy)

    Exercise: $25.74From: 2010-02-18Exp: 2019-02-18→ Common Stock (31,052 underlying)
    31,052

  • Stock Options (to buy)

    Exercise: $19.94From: 2009-11-20Exp: 2018-11-20→ Common Stock (7,763 underlying)
    7,763

  • Stock Options (to buy)

    Exercise: $36.65From: 2009-07-28Exp: 2018-07-28→ Common Stock (93,156 underlying)
    93,156
Footnotes (8)
  • [F1]The options will vest in equal increments of 1/3 on February 23, 2012, February 23, 2013 and February 23, 2014.
  • [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. These RSUs vest in three equal installments on 2/23/12, 2/23/13 and 2/23/14 . Unvested RSUs are forfeited at termination of employment.
  • [F3]The options will vest in equal increments of 1/3 on June 17, 2011, June 17 2012 and June 17, 2013.
  • [F4]The options will vest in equal increments of 1/3 on February 25, 2011, February 25, 2012 and February 25, 2013.
  • [F5]The options will vest in equal increments of 1/3 on February 18, 2010, February 18, 2011 and February 18, 2012.
  • [F6]The options will vest in equal increments of 1/3 on November 20, 2009, November 20, 2010 and November 20, 2011.
  • [F7]The options will vest in equal increments of 1/3 on October 3, 2009, October 3, 2010 and October 3, 2011.
  • [F8]The options vest in equal increments of 1/3 on July 28, 2009, July 28, 2010 and July 28, 2011.

Documents

1 file

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

→
Entity typeother

Related Parties

1
  • filerCIK 0001440766

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:14 PM ET
Size
17.1 KB
View on SEC.gov